Cargando…
A review of the treatment options for skin rash induced by EGFR-targeted therapies: Evidence from randomized clinical trials and a meta-analysis
BACKGROUND: Agents targeting the epidermal growth factor receptor (EGFR) are amongst the most extensively used of the targeted agents in the therapy of some of the most common solid tumors. Although they avoid many of the classic side effects associated with cytotoxic chemotherapy, they are associat...
Autores principales: | Ocvirk, Janja, Heeger, Steffen, McCloud, Philip, Hofheinz, Ralf-Dieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Versita, Warsaw
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691090/ https://www.ncbi.nlm.nih.gov/pubmed/23801914 http://dx.doi.org/10.2478/raon-2013-0014 |
Ejemplares similares
-
Evaluation of EGFR inhibitor‐mediated acneiform skin toxicity within the double‐blind randomized EVITA trial: A thorough gender‐specific analysis using the WoMo score
por: Gaiser, Maria R., et al.
Publicado: (2019) -
Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tumors
por: Hofheinz, Ralf-Dieter, et al.
Publicado: (2016) -
Management of cetuximab-induced skin toxicity with the prophylactic use of topical vitamin K1 cream
por: Ocvirk, Janja
Publicado: (2010) -
Predictive blood plasma biomarkers for EGFR inhibitor-induced skin rash
por: Hichert, Vivien, et al.
Publicado: (2017) -
Financial stress and mental health among higher education students in the UK up to 2018: rapid review of evidence
por: McCloud, Tayla, et al.
Publicado: (2019)